Clinical Trials Browser

Breast Carcinoma In Situ, Breast Neoplasms

NCT03145012 2023-02-08

Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity

Phase 4 Completed

30 enrolled

Tumor-Agnostic

Neoplasms

NCT05298683 2022-03-28

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Phase 2 Unknown

108 enrolled

Plasma cell

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT02999633 2022-03-21

ISLAY

Phase 2 Terminated

14 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01287520 2019-02-25

A Study of LY2090314 in Patients With Advanced or Metastatic Cancer

Phase 1 Completed

41 enrolled 28 charts

Advanced Cancer

NCT01332630 2018-09-20

TPI 287 in Breast Cancer Metastatic to the Brain

Phase 2 Completed

24 enrolled 8 charts

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT01539655 2017-05-02

Vandetanib

Phase 1 Completed

34 enrolled

Carcinoma, Medullary

NCT02441894 2017-01-24

PEGAZUS

Phase 4 Completed

21 enrolled

Genitourinary

Prostatic Neoplasms

NCT00030992 2012-08-20

BMS 247550 to Treat Kidney Cancer